These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9177968)

  • 1. Determination of the number of blood samples needed for optimal detection of cytomegalovirus viremia in immunocompromised patients using a shell-vial assay.
    Reina J; Blanco I; Munar M
    Eur J Clin Microbiol Infect Dis; 1997 Apr; 16(4):318-21. PubMed ID: 9177968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of detection of cytomegalovirus viremia in transplantation recipients by shell vial assay.
    Patel R; Klein DW; Espy MJ; Harmsen WS; Ilstrup DM; Paya CV; Smith TF
    J Clin Microbiol; 1995 Nov; 33(11):2984-6. PubMed ID: 8576358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shell-vial culture and pp65 antigenemia assay in the detection of cytomegalovirus in the first blood sample of renal transplant recipients.
    Reina J; Fernandez-Baca V; Saurina J; Blanco I; Munar M
    J Med Virol; 1998 Jul; 55(3):240-2. PubMed ID: 9624613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the murex hybrid capture cytomegalovirus DNA assay versus plasma PCR and shell vial assay for diagnosis of human cytomegalovirus viremia in immunocompromised patients.
    Barrett-Muir WY; Aitken C; Templeton K; Raftery M; Kelsey SM; Breuer J
    J Clin Microbiol; 1998 Sep; 36(9):2554-6. PubMed ID: 9705391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients.
    Matsunaga T; Sakamaki S; Ishigaki S; Kohda K; Takeda M; Katoh J; Kuroda H; Hirayama Y; Kusakabe T; Akiyama T; Kuga T; Niitsu Y; Masaoka T; Sagawa T; Matsumoto Y
    Int J Hematol; 1999 Feb; 69(2):105-11. PubMed ID: 10071460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection in a seroendemic renal transplant population: a longitudinal study of virological markers.
    Rao M; Finny GJ; Abraham P; Juneja R; Thomas PP; Jacob CK; Sridharan G
    Nephron; 2000 Apr; 84(4):367-73. PubMed ID: 10754415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Performance of the IgG avidity test in patients with cytomegalovirus disease].
    Lafarga B; Noguera FJ; Bolanos M; Pérez MC; Rodríguez H
    Enferm Infecc Microbiol Clin; 1997 Apr; 15(4):190-5. PubMed ID: 9312277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
    Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
    BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of urine and blood cultures for diagnosing cytomegalovirus infection in the kidney transplant recipient].
    Reina Prieto J; Bestard Palmer X; Saurina Gomila J; Gascó Company J; Fernández-Baca Gutiérrez del Alamo V; Munar Roca M
    Rev Clin Esp; 1998 Jan; 198(1):3-6. PubMed ID: 9534340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blinded, prospective study to define antigenemia and quantitative real-time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients.
    David-Neto E; Triboni AH; Paula FJ; Vilas Boas LS; Machado CM; Agena F; Latif AZ; Alencar CS; Pierrotti LC; Nahas WC; Caiaffa-Filho HH; Pannuti CS
    Transplantation; 2014 Nov; 98(10):1077-81. PubMed ID: 24839894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
    Solano C; Muñoz I; Gutiérrez A; Farga A; Prósper F; García-Conde J; Navarro D; Gimeno C
    J Clin Microbiol; 2001 Nov; 39(11):3938-41. PubMed ID: 11682510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric disease and cytomegalovirus viremia in renal transplant recipients.
    Hibberd PL; Surman OS; Bass M; Tolkoff-Rubin NE; Cosimi AB; Schooley RT; Doran M; Delvecchio A; Rosal M; Rubin R
    Psychosomatics; 1995; 36(6):561-3. PubMed ID: 7501787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection.
    Zurlo JJ; O'Neill D; Polis MA; Manischewitz J; Yarchoan R; Baseler M; Lane HC; Masur H
    Ann Intern Med; 1993 Jan; 118(1):12-7. PubMed ID: 8093214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The usefulness of the shell-vial culture in the diagnosis of cytomegalovirus infection in renal transplantation patients].
    Reina J; Blanco I; Munar M; Mari M
    Enferm Infecc Microbiol Clin; 1998 Dec; 16(10):493-4. PubMed ID: 9919004
    [No Abstract]   [Full Text] [Related]  

  • 15. [Investigation of cytomegalovirus positivity in the peripheral blood samples of risky patients by shell-vial cell culture, antigenemia test and real-time polymerase chain reaction].
    Gökahmetoğlu S; Yağmur G; Mutlu Sarıgüzel F; Deniz E
    Mikrobiyol Bul; 2011 Apr; 45(2):288-95. PubMed ID: 21644072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Virologic analysis of 1,000 blood samples processed for cytomegalovirus isolation (viremia) and pp65 antigenemia in immunodepressed patients].
    Reina J; Riera M; Bestard X; Villalonga C; Gascó J
    Med Clin (Barc); 1998 Mar; 110(8):281-4. PubMed ID: 9567253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance and risk factors of untreated cytomegalovirus viremia in liver transplant recipients.
    Badley AD; Patel R; Portela DF; Harmsen WS; Smith TF; Ilstrup DM; Steers JL; Wiesner RH; Paya CV
    J Infect Dis; 1996 Feb; 173(2):446-9. PubMed ID: 8568308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course of cytomegalovirus (CMV) viremia with and without ganciclovir treatment in CMV-seropositive kidney transplant recipients. Longitudinal follow-up of CMV pp65 antigenemia assay.
    Yang CW; Kim YO; Kim YS; Kim SY; Moon IS; Ahn HJ; Koh YB; Bang BK
    Am J Nephrol; 1998; 18(5):373-8. PubMed ID: 9730559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choice of antibody immunotherapy influences cytomegalovirus viremia in simultaneous pancreas-kidney transplant recipients.
    Huurman VA; Kalpoe JS; van de Linde P; Vaessen N; Ringers J; Kroes AC; Roep BO; De Fijter JW
    Diabetes Care; 2006 Apr; 29(4):842-7. PubMed ID: 16567825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of leukocyte concentration and inoculum volume on the laboratory identification of cytomegalovirus in peripheral blood by the centrifugation culture-antigen detection methodology.
    Lipson SM; Falk LH; Lee SH
    Arch Pathol Lab Med; 1996 Jan; 120(1):53-6. PubMed ID: 8554445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.